Problems in the Design and Reporting of Trials of Antifungal Agents Encountered During Meta-analysis

Johansen, Helle Krogh·1999·JAMA
DOI 10.1001/jama.282.18.1752

Cited by (128)

Items 101–128 of 128

  1. Clinical Trials Abroad: The Marketable Ethics, Weak Protections and Vulnerable Subjects of EU Law
    Mark Leslie Flear · 2014 · Cambridge yearbook of European legal studies
  2. Expanding the Evidence Base in Transplantation: More and Better Randomized Trials, and Extending the Value of Observational Data
    Jonathan C. Craig, Angela Claire Webster, Andrew S Mitchell, Les Irwig · 2008 · Transplantation
  3. Clinical Research and Industrial Sponsoring: Avenues towards Transparency and Credibility
    M. Hildebrandt, W.-D. Ludwig · 2003 · Oncology Research and Treatment
  4. Marketing, Media, Wishful Thinking, and Conflicts of Interest: Inflating the Value of New Medical Technology
    Richard A. Deyo · 2009 · The Permanente Journal
  5. Bias related to funding source in statin trials The biases are clear if you know where to look
    Lisa Anne Bero · 2014
  6. Publication ethics: obligations of authors, peer-reviewers, and editors
    Gail A. Van Norman, Stephen Jackson · 2010 · Cambridge University Press eBooks
  7. Biomedical Research: A Systematic Review Scope and Impact of Financial Conflicts of Interest in
    Justin E. Bekelman, Yan Li, Cary Philip Gross · 2010
  8. Medical Literature and Evidence-Based Medicine
    Kelly D. Young, Roger J. Lewis · 2010 · Elsevier eBooks
  9. Privatization of Science – A Silent Phenomenon
    Lidija Gajski · 2019 · Pannoniana
  10. Itraconazole versus Fluconazole for Antifungal Prophylaxis
    Sherif Beniameen Mossad · 2004 · Annals of Internal Medicine
  11. Ronda clínica y epidemiológica
    Óscar Osío Uribe, John Jairo Zuleta Tobón · 2008 · IATREIA
  12. Traditional and new markers of infection in adult cancer patients and the possible interfering effect of underlying malignancy on these markers
    Raija S. Kallio · 2000
  13. The Importance of Clinical Research for Plant-Derived Medicines
    Timothy N. Gorski · 2001 · Springer eBooks
  14. Errores sistemáticos en la medición de la eficacia terapéutica
    Óscar Osío Uribe · 2007 · IATREIA
  15. Interpreting Clinical Evidence
    Nick Freemantle, Joanne Eastaugh, Melanie Calvert, Suzanne Rose Hill, Jesse A. Berlin · 2004
  16. Who Determines the Research Agenda?
    Lars Werkö · 2000 · Scandinavian Cardiovascular Journal
  17. UNSUBSTANTIATED CLAIMS IN PATIENT BROCHURES FROM THE LARGEST STATE, PROVINCIAL, AND NATIONAL CHIROPRACTIC ASSOCIATIONS AND RESEARCH AGENCIES
    Anthony Leopold Rosner · 2002 · Journal of Manipulative and Physiological Therapeutics
  18. Letter regarding Zhu et al. entitled “Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility”
    Jue‐Yu Zhou, Rong Shi, Lei Jiang, Ye Zeng, Wenli Ma · 2014 · Tumor Biology
  19. Reproductive medicine and research: contract laboratories vs. the university-based researcher
    Richard E. Blackwell · 2000 · Fertility and Sterility
  20. Conflicts of interest in biomedical publishing
    Andreas Lundh · 2012
  21. Reviewbias in medical research - a narrative review
    Natalie McGauran, Beate Wieseler, Julia Kreis, Yvonne-Beatrice Schüler, Heike Kölsch, Thomas Kaiser · 2010
  22. Protocol-writing support conferences for investigator-initiated clinical trials
    Masaya Goto, Yoshihiro Muragaki, Atsushi Aruga · 2016 · Open Access Journal of Clinical Trials
  23. Trials, meta-analyses, bedrog
    , · 2001 · Huisarts en Wetenschap
  24. Analysis Issues – A Lot of Choices
    2008 · Springer eBooks
  25. Trials, meta-analyses, bedrog
    , · 2001 · Medisch-Farmaceutische Mededelingen
  26. Improving the Conduct and Reporting of Clinical Trials
    Lon S. S. Schneider · 2000 · JAMA
  27. Improving the Conduct and Reporting of Clinical Trials
    Helene Panzer · 2000 · JAMA
  28. Improving the Conduct and Reporting of Clinical Trials
    Hannelore Bernhardt · 2000 · JAMA